Table V.
OR value and 95% CI of adverse events after PTRAS with different comorbidities.
| Comorbidity | Adverse event, n (%) | OR (95% CI) | P-value |
|---|---|---|---|
| Sex | |||
| Male | 33 (58.9) | 1.193 (0.648–2.197) | 0.644 |
| Female | 23 (41.1) | ||
| Age (years) | |||
| ≥65 | 41 (73.2) | 2.610 (1.347–5.060) | 0.005 |
| <65 | 15 (26.8) | ||
| CCI score | |||
| 1 | 3 (5.4) | 1.0 | |
| 2 | 10 (17.9) | 4.136 (1.084–15.780) | 0.039 |
| 3 | 29 (51.8) | 15.421 (4.419–53.807) | <0.001 |
| ≥4 | 14 (25) | 28.424 (7.001–115.325) | <0.001 |
| Smoking history | 32 (57.1) | 1.641 (0.894–3.013) | 0.125 |
| Diabetes mellitus | 21 (37.5) | 2.147 (1.121–4.112) | 0.023 |
| Stroke | 26 (46.4) | 3.209 (1.695–6.077) | <0.001 |
| Hyperlipidemia | 29 (51.8) | 0.758 (0.414–1.388) | 0.438 |
| CHF | 25 (44.6) | 3.446 (1.801–6.594) | <0.001 |
OR, odds ratio; CI, confidence interval; PTRAS, percutaneous renal artery stent implantation; CCI, Charlson comorbidity index; CHF, congestive heart failure.